A detailed history of Federated Hermes, Inc. transactions in A Tyr Pharma Inc stock. As of the latest transaction made, Federated Hermes, Inc. holds 14,666,600 shares of LIFE stock, worth $27.3 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
14,666,600
Previous 10,169,600 44.22%
Holding current value
$27.3 Million
Previous $19.8 Million 15.38%
% of portfolio
0.06%
Previous 0.05%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$0.0 - $2.07 $0 - $9.31 Million
4,497,000 Added 44.22%
14,666,600 $22.9 Million
Q3 2023

Nov 13, 2023

SELL
$1.55 - $2.23 $31,567 - $45,416
-20,366 Reduced 0.2%
10,169,600 $16.1 Million
Q1 2023

May 08, 2023

BUY
$1.88 - $2.5 $9.32 Million - $12.4 Million
4,958,366 Added 94.78%
10,189,966 $21.4 Million
Q4 2022

Feb 13, 2023

BUY
$2.02 - $2.49 $18,887 - $23,281
9,350 Added 0.18%
5,231,600 $11.5 Million
Q3 2021

Nov 15, 2021

BUY
$4.22 - $12.48 $15.2 Million - $45 Million
3,607,250 Added 223.36%
5,222,250 $47.4 Million
Q1 2020

May 13, 2020

BUY
$2.17 - $7.06 $2.21 Million - $7.2 Million
1,019,928 Added 171.4%
1,615,000 $4.52 Million
Q4 2019

Feb 14, 2020

BUY
$3.03 - $4.83 $136,568 - $217,697
45,072 Added 8.19%
595,072 $2.48 Million
Q3 2019

Nov 14, 2019

BUY
$2.8 - $5.46 $1.54 Million - $3 Million
550,000 New
550,000 $1.93 Million

Others Institutions Holding LIFE

About aTYR PHARMA INC


  • Ticker LIFE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,625,000
  • Market Cap $53.2M
  • Description
  • aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...
More about LIFE
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.